Effectiveness of zonisamide in a patient with Parkinson's disease and various levodopa-induced psychotic symptoms

被引：3
|
作者：
Yabe, Ichiro [1 ]
Ohta, Midori [2 ]
Egashira, Toshiaki [3 ]
Sato, Kazunori [1 ]
Kano, Takahiro [1 ]
Hirotani, Makoto [1 ]
Kunieda, Yasuyuki [4 ]
Sasaki, Hidenao [1 ]
机构：
[1] Hokkaido Univ, Grad Sch Med, Dept Neurol, Sapporo, Hokkaido, Japan
[2] Wakkanai City Hosp, Rehabil Ctr, Wakkanai, Hokkaido, Japan
[3] Wakkanai City Hosp, Dept Psychiat, Wakkanai, Hokkaido, Japan
[4] Wakkanai City Hosp, Dept Internal Med, Wakkanai, Hokkaido, Japan
来源：
NEUROLOGY AND CLINICAL NEUROSCIENCE | 2014年 / 2卷 / 06期
关键词：
dopamine agonists; levodopa; Parkinson's disease; psychotic symptoms; zonisamide;
D O I：
10.1111/ncn3.126
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Levodopa and dopamine agonists are useful as Parkinson's disease medications. However, they often induce persistent psychotic symptoms and motor complications, which make Parkinson's disease treatment difficult. This is a case report of a patient with advanced Parkinson's disease accompanied by exacerbation of motor symptoms and psychotic symptoms derived from prolonged use of conventional anti-Parkinson's disease drugs, and in whom adjunctive therapy with a new anti Parkinson's disease drug, zonisamide, was shown to improve motor symptoms with no exacerbation of psychotic symptoms.
引用
收藏
页码：201 / 203
页数：3
相关论文
共 50 条
  • [31] On Automated Assessment of Levodopa-Induced Dyskinesia in Parkinson's Disease
    Tsipouras, Markos G.
    Tzallas, Alexandros T.
    Fotiadis, Dimitrios I.
    Konitsiotis, Spyridon
    2011 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2011, : 2679 - 2682
  • [32] Riluzole for levodopa-induced dyskinesias in advanced Parkinson's disease
    Merims, D
    Ziv, I
    Djaldetti, R
    Melamed, E
    LANCET, 1999, 353 (9166): : 1764 - 1765
  • [33] Handicap in Parkinson's disease with levodopa-induced motor complications
    Coelho, M.
    Correia Guedes, L.
    Lobo, P. Pita
    Abreu, D.
    Albuquerque, L.
    Pereira, J. M.
    Rosa, M. M.
    Ferreira, J. J.
    JOURNAL OF NEUROLOGY, 2014, 261 : S291 - S291
  • [34] Pharmacokinetic factors and levodopa-induced dyskinesia in Parkinson's disease
    Oeda, T.
    Umemura, A.
    Tomita, S.
    Kohsaka, M.
    Park, K.
    Mori, Y.
    Sawada, H.
    MOVEMENT DISORDERS, 2015, 30 : S107 - S107
  • [35] Risk factors for levodopa-induced dyskinesias in Parkinson's disease
    Grandas, F
    Galiano, ML
    Tabernero, C
    JOURNAL OF NEUROLOGY, 1999, 246 (12) : 1127 - 1133
  • [36] Levodopa-induced dyskinesias in Parkinson's disease: emerging treatments
    Bargiotas, Panagiotis
    Konitsiotis, Spyridon
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 1605 - 1617
  • [37] Biphasic Levodopa-Induced Freezing of Gait in Parkinson's Disease
    Nonnekes, Jorik
    Bloem, Bastiaan R.
    JOURNAL OF PARKINSONS DISEASE, 2020, 10 (03) : 1245 - 1248
  • [38] Handicap in Parkinson's disease with levodopa-induced motor complications
    Coelho, M.
    Correia Guedes, L.
    Pita Lobo, P.
    Abreu, D.
    Albuquerque, L.
    Pereira, J. M.
    Rosa, M. M.
    Ferreira, J. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 439 - 439
  • [39] Risperidone and suppression of levodopa-induced dyskinesia in Parkinson's disease
    Parsa, MA
    Greenaway, HM
    Mangat, TS
    BIOLOGICAL PSYCHIATRY, 1999, 45 (08) : 137S - 137S
  • [40] Levodopa-induced dyskinesias in Parkinson's disease: Is sensitization reversible?
    Bejjani, BP
    Arnulf, I
    Demeret, S
    Damier, P
    Bonnet, AM
    Houeto, JL
    Agid, Y
    ANNALS OF NEUROLOGY, 2000, 47 (05) : 655 - 658
12345